Inactive Ingredient Search for Approved Drug Products

Latest News: FDA announced upcoming changes to the Inactive Ingredient Database: more information


Search Names Beginning with I

Inactive Ingredient Route Dosage Form CAS Number UNII Maximum Potency per unit dose Record Updated
ICODEXTRIN ORAL GRANULE, FOR SOLUTION 337376155 2NX48Z0A9G 4.4mg/ml
ICODEXTRIN ORAL POWDER, FOR SOLUTION 337376155 2NX48Z0A9G 12.5mg/5ml
ICODEXTRIN ORAL SOLUTION 337376155 2NX48Z0A9G 20mg/5ml
ICODEXTRIN ORAL TABLET 337376155 2NX48Z0A9G 8mg
ICODEXTRIN ORAL TABLET, COATED 337376155 2NX48Z0A9G 10mg
ICODEXTRIN ORAL TABLET, DELAYED RELEASE 337376155 2NX48Z0A9G 9.25mg
ICODEXTRIN ORAL TABLET, EXTENDED RELEASE 337376155 2NX48Z0A9G 6mg
ICODEXTRIN TOPICAL CREAM 337376155 2NX48Z0A9G 0.03%w/w
ICODEXTRIN TOPICAL LOTION 337376155 2NX48Z0A9G NA
ICODEXTRIN TOPICAL SHAMPOO 337376155 2NX48Z0A9G 5%w/w
IMIDUREA TOPICAL CREAM 39236469 M629807ATL 0.4%w/w
IMIDUREA TOPICAL LOTION 39236469 M629807ATL 0.2%w/w
IMIDUREA TOPICAL SHAMPOO 39236469 M629807ATL 0.4%w/w
INDIGOTINDISULFONATE SODIUM ORAL CAPSULE 860220 D3741U8K7L 0.68mg
INDIGOTINDISULFONATE SODIUM ORAL TABLET 860220 D3741U8K7L 2.87mg
INDIGOTINDISULFONATE SODIUM ORAL TABLET, EXTENDED RELEASE 860220 D3741U8K7L 0.04mg
INK BLACK 2271 ORAL CAPSULE NA
INK BLACK A-10464 ORAL TABLET, EXTENDED RELEASE NA
INK BLACK A-10527 ORAL TABLET, EXTENDED RELEASE 0.19mg
INK BLACK FGE-1386 ORAL CAPSULE NA
INK BLACK SW-9007 ORAL TABLET 0.09mg
INK BLACK SW-9007 ORAL TABLET, FILM COATED 0.09mg
INK BLACK SW-9008 NASAL POWDER NA
INK BLACK SW-9008 ORAL CAPSULE 0.91mg
INK BLACK SW-9008 ORAL CAPSULE, COATED NA
INK BLACK SW-9008 ORAL CAPSULE, DELAYED RELEASE 0.17mg
INK BLACK SW-9008 ORAL CAPSULE, EXTENDED RELEASE 1.29mg
INK BLACK SW-9009 ORAL CAPSULE NA
INK BLACK SW-9009 ORAL CAPSULE, EXTENDED RELEASE NA
INK BLUE TEK PRINT SB-6029 ORAL CAPSULE NA
INK BLUE TEK PRINT SB-6029 ORAL TABLET, EXTENDED RELEASE 0.2mg
INK BLUE TEKPRINT SB-6018 ORAL CAPSULE 63.31mg
INK BLUE TEKPRINT SB-6018 ORAL CAPSULE, EXTENDED RELEASE 0.04mg
INK EDIBLE BLACK ORAL CAPSULE 0.25mg
INK EDIBLE BLACK ORAL TABLET 0.2mg
INK EDIBLE BLACK ORAL TABLET, COATED 0.4mg
INK EDIBLE BLACK ORAL TABLET, EXTENDED RELEASE 1mg
INK EDIBLE BLUE ORAL CAPSULE 1mg
INK EDIBLE BLUE ORAL TABLET NA
INK EDIBLE BLUE ORAL TABLET, COATED 0.04mg
INK EDIBLE BLUE ORAL TABLET, FILM COATED NA
INK EDIBLE BROWN ORAL TABLET, COATED 0.04mg
INK EDIBLE GRAY ORAL CAPSULE NA
INK EDIBLE RED ORAL CAPSULE NA
INK EDIBLE RED ORAL TABLET 0.01mg
INK EDIBLE RED ORAL TABLET, COATED NA
INK EDIBLE RED ORAL TABLET, DELAYED RELEASE NA
INK EDIBLE WHITE ORAL CAPSULE NA
INK EDIBLE WHITE ORAL CAPSULE, EXTENDED RELEASE 0.04mg
INK EDIBLE WHITE ORAL TABLET, COATED NA
INK EDIBLE WHITE ORAL TABLET, EXTENDED RELEASE 0.19mg
INK EDIBLE WHITE ORAL TABLET, FILM COATED NA
INK FINE BLACK 2202C ORAL TABLET NA
INK FINE BLACK 2212 ORAL TABLET NA
INK FINE BLACK 2212 ORAL TABLET, EXTENDED RELEASE NA
INK RED A-8032 ORAL CAPSULE NA
INK RED A-8032 ORAL TABLET, COATED NA
INK S-1-7085 ORAL CAPSULE NA
INK WHITE A-8154 ORAL CAPSULE 0.8mg
INK WHITE A-8154 ORAL TABLET NA
INK WHITE SB-0007P ORAL CAPSULE 0.91mg
INK WHITE SW-0012 ORAL CAPSULE NA
INK WHITE SW-0012 ORAL CAPSULE, DELAYED RELEASE NA
INK WHITE SW-0012 ORAL TABLET 0.2mg
INVERT SUGAR ORAL CAPSULE 8013170 ED959S6ACY NA
INVERT SUGAR ORAL SOLUTION 8013170 ED959S6ACY 3.06ml/5ml
INVERT SUGAR ORAL SYRUP 8013170 ED959S6ACY 2560mg/5ml
IRON ORAL TABLET, EXTENDED RELEASE 7439896 E1UOL152H7 5mg
ISOBUTANE RECTAL AEROSOL, FOAM 75285 BXR49TP611 5.52%w/w
ISOBUTANE TOPICAL AEROSOL 75285 BXR49TP611 82.4%w/w
ISOBUTANE TOPICAL AEROSOL, SPRAY 75285 BXR49TP611 82.39%w/w
ISOBUTANE TOPICAL SPRAY 75285 BXR49TP611 82.4%w/w
ISOBUTYL ALCOHOL ORAL TABLET, COATED 78831 56F9Z98TEM NA
ISOLEUCINE INTRAVENOUS INJECTION 73325 04Y7590D77 406mg
ISOLEUCINE INTRAVENOUS INJECTION, SOLUTION 73325 04Y7590D77 0.21%w/v
ISOMALT ORAL CAPSULE 64519820 S870P55O2W 73mg
ISOMALT ORAL TABLET 64519820 S870P55O2W 522mg
ISOMALT ORAL TROCHE 64519820 S870P55O2W 1718.71mg
ISOMALT SUBLINGUAL POWDER 64519820 S870P55O2W 176.8mg
ISOOCTYL ACRYLATE/ACRYLAMIDE/VINYL ACETATE COPOLYMER, KOLLIDON VA 64 POLYMER ORAL TABLET, FILM COATED 53mg
ISOOCTYL ACRYLATE/ACRYLAMIDE/VINYL ACETATE COPOLYMER, KOLLIDON VA 64 POLYMER TOPICAL SPONGE 5.4%w/w
ISOPROPYL ALCOHOL ORAL CAPSULE 67630 ND2M416302 NA
ISOPROPYL ALCOHOL TOPICAL SPONGE 67630 ND2M416302 4%w/w
ISOPROPYL ALCOHOL TOPICAL SWAB 67630 ND2M416302 43.9%w/w
ISOPROPYL ISOSTEARATE TOPICAL CREAM 68171335 C67IXB9Y7T 3%w/w
ISOPROPYL MYRISTATE AURICULAR (OTIC) OIL 110270 0RE8K4LNJS 3.85%v/v
ISOPROPYL MYRISTATE AURICULAR (OTIC) SUSPENSION 110270 0RE8K4LNJS 0.02%w/w
ISOPROPYL MYRISTATE TOPICAL AEROSOL 110270 0RE8K4LNJS 9.3%w/w
ISOPROPYL MYRISTATE TOPICAL AEROSOL, FOAM 110270 0RE8K4LNJS 7.9%w/w
ISOPROPYL MYRISTATE TOPICAL AEROSOL, SPRAY 110270 0RE8K4LNJS 6.89%w/w
ISOPROPYL MYRISTATE TOPICAL CREAM 110270 0RE8K4LNJS 15%w/w
ISOPROPYL MYRISTATE TOPICAL CREAM, AUGMENTED 110270 0RE8K4LNJS 8%w/w
ISOPROPYL MYRISTATE TOPICAL GEL 110270 0RE8K4LNJS 10%w/w
ISOPROPYL MYRISTATE TOPICAL LOTION 110270 0RE8K4LNJS 5%w/w
ISOPROPYL MYRISTATE TOPICAL OIL 110270 0RE8K4LNJS 3.12%w/v
ISOPROPYL MYRISTATE TOPICAL OINTMENT 110270 0RE8K4LNJS 35%w/w
ISOPROPYL MYRISTATE TOPICAL PATCH, EXTENDED RELEASE 110270 0RE8K4LNJS 0.07mg/mg
ISOPROPYL MYRISTATE TOPICAL SPRAY 110270 0RE8K4LNJS 41.3%w/v
ISOPROPYL MYRISTATE TOPICAL SUPPOSITORY 110270 0RE8K4LNJS 0.01mg/mg
ISOPROPYL MYRISTATE TRANSDERMAL FILM, EXTENDED RELEASE 110270 0RE8K4LNJS 20.4mg
ISOPROPYL MYRISTATE TRANSDERMAL GEL 110270 0RE8K4LNJS 1%w/w
ISOPROPYL MYRISTATE TRANSDERMAL GEL, METERED 110270 0RE8K4LNJS 1%w/w
ISOPROPYL MYRISTATE TRANSDERMAL PATCH 110270 0RE8K4LNJS 7.25mg
ISOPROPYL MYRISTATE VAGINAL CREAM 110270 0RE8K4LNJS 1%w/w
ISOPROPYL PALMITATE TOPICAL AEROSOL 142916 8CRQ2TH63M 7.3%w/w
ISOPROPYL PALMITATE TOPICAL AEROSOL, SPRAY 142916 8CRQ2TH63M 7.3%w/w
ISOPROPYL PALMITATE TOPICAL CREAM 142916 8CRQ2TH63M 5%w/w
ISOPROPYL PALMITATE TOPICAL CREAM, AUGMENTED 142916 8CRQ2TH63M 4%w/w
ISOPROPYL PALMITATE TOPICAL GEL 142916 8CRQ2TH63M NA
ISOPROPYL PALMITATE TOPICAL LOTION 142916 8CRQ2TH63M 5%w/w
ISOPROPYL PALMITATE TOPICAL OINTMENT 142916 8CRQ2TH63M NA
ISOPROPYL PALMITATE TOPICAL SPRAY 142916 8CRQ2TH63M 7.3%w/w
ISOPROPYL PALMITATE TRANSDERMAL FILM 142916 8CRQ2TH63M 1.81mg
ISOPROPYL PALMITATE TRANSDERMAL FILM, EXTENDED RELEASE 142916 8CRQ2TH63M 13.77mg
ISOSTEARIC ACID TOPICAL CREAM 30399849 X33R8U0062 25%w/w
ISOSTEARIC ACID TOPICAL OINTMENT 30399849 X33R8U0062 NA
ISOSTEARIC ACID TRANSDERMAL GEL 30399849 X33R8U0062 0.2%w/w
ISOSTEARYL ALCOHOL TOPICAL CREAM 27458931 Q613OCQ44Y 3%w/w
ISOSTEARYL ALCOHOL TOPICAL LOTION 27458931 Q613OCQ44Y 2.5%w/w
ISOSTEARYL ALCOHOL TOPICAL OINTMENT 27458931 Q613OCQ44Y NA
ISOSTEARYL ALCOHOL TOPICAL SUSPENSION 27458931 Q613OCQ44Y 2.5%w/w
ISOTONIC SODIUM CHLORIDE SOLUTION EPIDURAL INJECTION, SUSPENSION, LIPOSOMAL 7647145 VR5Y7PDT5W 0.57%w/v
ISOTONIC SODIUM CHLORIDE SOLUTION INTRAVENOUS INJECTION 7647145 VR5Y7PDT5W 0.9%w/v
ISOTONIC SODIUM CHLORIDE SOLUTION INTRAVENOUS SOLUTION 7647145 VR5Y7PDT5W 0.9%w/v

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: July 5, 2019
Database Last Updated: July 24, 2019

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English